OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 37 filers reported holding OVID THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $114,275 | +21.4% | 29,759 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $94,139 | -15.2% | 28,701 | +3.5% | 0.00% | – |
| Q1 2021 | $111,000 | +73.4% | 27,729 | +0.3% | 0.00% | – |
| Q4 2020 | $64,000 | -56.5% | 27,655 | +8.0% | 0.00% | -100.0% |
| Q3 2020 | $147,000 | -23.8% | 25,600 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $193,000 | +1186.7% | 26,183 | +211.7% | 0.00% | – |
| Q1 2019 | $15,000 | -28.6% | 8,401 | -3.1% | 0.00% | – |
| Q4 2018 | $21,000 | -58.0% | 8,674 | -0.8% | 0.00% | – |
| Q3 2018 | $50,000 | -25.4% | 8,741 | +1.8% | 0.00% | – |
| Q2 2018 | $67,000 | +21.8% | 8,583 | +9.5% | 0.00% | – |
| Q1 2018 | $55,000 | +61.8% | 7,840 | +130.4% | 0.00% | – |
| Q4 2017 | $34,000 | +17.2% | 3,403 | +0.5% | 0.00% | – |
| Q3 2017 | $29,000 | -12.1% | 3,386 | +8.1% | 0.00% | – |
| Q2 2017 | $33,000 | – | 3,132 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,252,892 | $10,930,000 | 4.97% |
| GLOBEFLEX CAPITAL L P | 1,397,770 | $4,697,000 | 1.02% |
| BVF INC/IL | 6,631,051 | $22,280,000 | 0.87% |
| EcoR1 Capital, LLC | 6,082,200 | $20,436,000 | 0.71% |
| Ikarian Capital, LLC | 1,105,082 | $3,715,000 | 0.26% |
| CHI Advisors LLC | 233,510 | $785,000 | 0.23% |
| DCF Advisers, LLC | 141,701 | $476,000 | 0.21% |
| Artal Group S.A. | 2,500,000 | $8,400,000 | 0.19% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 766,901 | $2,577,000 | 0.07% |
| ACADIAN ASSET MANAGEMENT LLC | 1,903,162 | $6,394,000 | 0.02% |